Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Testing Enteric Coated Capsules for Acid Resistance – V 2.0

Posted on By

Capsule: SOP for Testing Enteric Coated Capsules for Acid Resistance – V 2.0

Standard Operating Procedure for Testing Enteric Coated Capsules for Acid Resistance

Department Capsule Manufacturing
SOP No. SOP/CM/196/2025
Supersedes SOP/CM/196/2022
Page No. Page 1 of 8
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This SOP defines the procedure for testing the acid resistance of enteric-coated capsules to ensure that they remain intact in acidic environments, as per regulatory requirements, before being released for use.

2. Scope

This SOP applies to all enteric-coated capsules produced at this facility and provides the procedure for testing the capsules’ ability to resist disintegration in acidic conditions, such as those encountered in the stomach.

3. Responsibilities

  • Quality Control (QC) Team: Responsible for performing the acid resistance testing and recording the results in compliance with the protocol.
  • Quality Assurance (QA) Team: Ensures the testing procedures are followed accurately and reviews the results to ensure compliance with regulatory requirements.
  • Production Team: Provides the required samples of enteric-coated capsules for testing and ensures proper handling during the production process.

4. Accountability

The QA Manager is accountable for overseeing the acid resistance testing and ensuring that the procedure is followed

according to GMP guidelines. The QC Supervisor ensures that testing is performed properly, and the Production Supervisor ensures that capsule batches meet the required quality standards.

See also  Capsule: SOP for Controlling Environmental Conditions During Dispensing - V 2.0

5. Procedure

5.1 Pre-Testing Setup

Before performing the acid resistance testing, ensure the following:

  1. Review Material Specifications

    1. Review the specifications for the enteric-coated capsules to confirm that they are designed to resist acid exposure, particularly at the pH level typical for gastric conditions (pH 1.2).
  2. Prepare Testing Equipment

    1. Ensure that the disintegration testing apparatus is calibrated and set up according to the prescribed standards (e.g., USP <701> for disintegration).
    2. Prepare the test medium, which should consist of a simulated gastric fluid (SGF) at pH 1.2.
  3. Sample Collection

    1. Collect a representative sample of the enteric-coated capsules from the batch. Typically, 6 capsules are selected for testing, but this may vary depending on batch size and regulatory guidelines.

5.2 Acid Resistance Testing Procedure

Follow these steps to conduct the acid resistance test:

  1. Set Up the Disintegration Apparatus

    1. Place the disintegration testing apparatus in the proper location and ensure the bath is filled with the pre-warmed SGF at pH 1.2 (simulated gastric fluid).
    2. Ensure the apparatus is operating at the correct temperature (37°C ± 2°C) to simulate physiological conditions.
  2. Test the Capsules

    1. Place each capsule in the disintegration basket of the apparatus. Start the testing cycle and observe the capsules for any signs of disintegration.
    2. Continue the test for up to 2 hours or until the capsule’s coating begins to dissolve or the capsule disintegrates.
  3. Observation and Documentation

    1. Note the time at which the enteric coating begins to dissolve or when disintegration occurs. The capsules should not show any sign of disintegration during the first 60 minutes in the acidic medium.
    2. Record the time taken for each capsule to show any disintegration or coating damage.

5.3 Post-Testing Activities

After completing the acid resistance test, ensure the following:

  1. Review Results

    1. The QA Manager reviews the test results to ensure that the enteric-coated capsules meet the acceptance criteria, i.e., the capsules should not disintegrate in SGF at pH 1.2 within the first 60 minutes of testing.
  2. Corrective Actions

    1. If any capsules fail the acid resistance test (e.g., coating dissolves prematurely), the batch should be rejected, and an investigation should be initiated to identify the root cause.
  3. Reporting

    1. Provide the test results to the regulatory authorities if required, especially if any deviations or failures are encountered during testing.
  4. Record Keeping

    1. Ensure that all test results, observations, and corrective actions are properly documented and archived in accordance with GMP and regulatory guidelines.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • QC: Quality Control
  • SGF: Simulated Gastric Fluid
  • USP: United States Pharmacopeia
  • EP: European Pharmacopeia

7. Documents

  1. Annexure 1: Equipment Calibration Log
  2. Annexure 2: Acid Resistance Testing Log
  3. Annexure 3: Corrective Action Report

8. References

  • USP <701> – Disintegration of Tablets and Capsules
  • European Pharmacopoeia 2.9.1 – Dissolution Testing
  • Good Manufacturing Practice (GMP) Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure 1: Equipment Calibration Log

Equipment ID Calibration Date Operator Calibration Details Next Calibration Due
Disintegration Apparatus 301 01/02/2025 John Doe Calibration of temperature and timing mechanism 01/02/2026

Annexure 2: Acid Resistance Testing Log

Batch ID Test Date Disintegration Time (Minutes) Result Comments
Batch 010 02/02/2025 60 Pass No coating damage

Annexure 3: Corrective Action Report

Batch ID Deviation Corrective Action Responsible Person Completion Date
Batch 010 Coating dissolution at 45 minutes Adjusted coating process parameters Production Supervisor 03/02/2025

12. Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial version of SOP Creation of SOP for testing enteric coating QA Head
01/02/2025 2.0 Updated test method and log format Improvement of testing accuracy and compliance QA Head
See also  Capsule: SOP for Validation of Water Systems for Capsule Shell Production - V 2.0
Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

Post navigation

Previous Post: Creams: SOP for Setting Parameters for Planetary Mixers – V 2.0
Next Post: BA-BE Studies: SOP for IEC/IRB Continuing Review Applications – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version